Published in Cancer Weekly, May 19th, 2009
"We retrospectively analyzed the clinical parameters of 224 patients with unresectable HCC treated with repeated TALE from January 1997 to December 2007. TALE was repeated when recurrence was diagnosed by tumor marker elevation and/or dynamic computed tomography findings. Factors...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.